We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Aquestive Therapeutics Hit With Complete Response Letter for Libervant
Aquestive Therapeutics Hit With Complete Response Letter for Libervant
The FDA has issued Aquestive Therapeutics a complete response letter (CRL) for its Libervant (diazepam buccal film) for the management of seizure clusters.